Efficacy and Safety of Shexiang Baoxin Pill in Patients With Ischemia With Non-Obstructive Coronary Artery
Clinical trial NCT04897126 · COMPLETED
Trial details
- NCT number
- NCT04897126
- Sponsor
- Shanghai Hutchison Pharmaceuticals Limited
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-11
- Primary completion
- 2023-07-04
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.